Your browser doesn't support javascript.
loading
Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials.
Chemaly, Roy F; Chou, Sunwen; Einsele, Hermann; Griffiths, Paul; Avery, Robin; Razonable, Raymund R; Mullane, Kathleen M; Kotton, Camille; Lundgren, Jens; Komatsu, Takashi E; Lischka, Peter; Josephson, Filip; Douglas, Cameron M; Umeh, Obi; Miller, Veronica; Ljungman, Per.
Afiliação
  • Chemaly RF; Department of Infectious Diseases, Infection Control, and Employee Health, University of Texas MD Anderson Cancer Center, Houston.
  • Chou S; Division of Infectious Diseases, Oregon Health and Science University, and Research and Development Service, Veterans Affairs Portland Health Care System.
  • Einsele H; Department of Internal Medicine II, University Hospital Wuerzburg, Germany.
  • Griffiths P; Institute for Immunity and Transplantation, University College London Medical School, United Kingdom.
  • Avery R; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University, Baltimore, Maryland.
  • Razonable RR; Division of Infectious Diseases, Department of Medicine, William J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, Minnesota.
  • Mullane KM; Section of Infectious Diseases and Global Health, Department of Medicine, University of Chicago, Illinois.
  • Kotton C; Infectious Diseases Division, Massachusetts General Hospital, Harvard Medical School, Boston.
  • Lundgren J; Centre for Health and Infectious Disease Research, Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Denmark.
  • Komatsu TE; Division of Antiviral Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.
  • Lischka P; AiCuris Anti-infective Cures GmbH, Wuppertal, Germany.
  • Josephson F; Swedish Medical Products Agency, Uppsala.
  • Douglas CM; Merck & Co, Inc, Kenilworth, New Jersey.
  • Umeh O; Shire Global Clinical Development (Immunology Therapeutic Area), Lexington, Massachusetts.
  • Miller V; Forum for Collaborative Research, University of California, Berkeley.
  • Ljungman P; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital.
Clin Infect Dis ; 68(8): 1420-1426, 2019 04 08.
Article em En | MEDLINE | ID: mdl-30137245
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Transplante de Órgãos / Infecções por Citomegalovirus / Transplante de Células-Tronco Hematopoéticas / Transplantados Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Transplante de Órgãos / Infecções por Citomegalovirus / Transplante de Células-Tronco Hematopoéticas / Transplantados Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2019 Tipo de documento: Article